Saturday, April 18, 2015

Deals

Revolutionary Concepts’ Signs Major Licensing Agreement for Royalties

April 17, 2015 · Leave a Comment 

  CHARLOTTE, N.C., April 17, 2015 (GLOBE NEWSWIRE) — Revolutionary Concepts Inc., (OTCPINK:REVO), a publicly traded company that owns patented mobile video software and remote security communication systems, announced that its global licensee Eyetalk365, LLC, has reached a settlement in its patent infringement lawsuit with an international alarm and security systems company. Eyetalk365 LLC, has signed a Settlement and License Agreement with the alarm systems company to license some of REVO’s patent portfolio to them in exchange for the payment of royalties and fees. The agreement... [Read the full story]

Deal News

Revolutionary Concepts’ Signs Major Licensing Agreement for Royalties

April 17, 2015 · Leave a Comment 

  CHARLOTTE, N.C., April 17, 2015 (GLOBE NEWSWIRE) — Revolutionary Concepts Inc., (OTCPINK:REVO), a publicly traded company that owns patented mobile video software and remote security communication systems, announced that its global licensee Eyetalk365, LLC, has reached a settlement in its patent infringement lawsuit with an international alarm and security systems company. Eyetalk365 LLC, has signed a Settlement and License Agreement with the alarm systems company to license some of REVO’s patent portfolio to them in exchange for the payment of royalties and fees. The agreement... [Read the full story]

Legal

Semafone and Eckoh agree to settlement

March 19, 2015 · Leave a Comment 

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed to a confidential settlement of their dispute over alleged infringement and invalidity of Semafone’s UK Patent (No. GB 2,473,376), to the mutual benefit of both parties.  Under the settlement, Semafone has granted a worldwide licence to their granted patents, trademarks and patent applications covering certain dual tone multi-frequency (“DTMF”) masking methods of taking secure payments over the phone, for the benefit of Eckoh, its customers and suppliers. In consideration of the licence, Eckoh... [Read the full story]

Bio

SELLAS Life Sciences Group and TrojanTec Sign Exclusive License Agreement

April 15, 2015 · Leave a Comment 

  NEW YORK and ZUG, Switzerland, April 15, 2015 /PRNewswire/ — SELLAS Life Sciences Group (SELLAS), a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive global collaboration and license agreement with TrojanTec Ltd, (TrojanTec), a UK-based Discovery Research and Development Company affiliated with Imperial College London, UK, for the development, marketing and commercialization of the innovative... [Read the full story]

University Tech Transfer

DiaCarta Licenses U of Potsdam

April 17, 2015 · Leave a Comment 

  NEW YORK(GenomeWeb) – DiaCarta and the University of Potsdam today announced a licensing agreement for the non-invasive early detection of colon cancer. DiaCarta is licensing the intellectual property around the university’s detection method and will develop and commercialize a test to detect colon cancer directly from stool samples. Under the terms of the agreement, DiaCarta will pay the university an upfront payment, as well as payments upon the achievement of milestones. In return, DiaCarta, a Hayward, Calif.-based molecular diagnostics company, will have the exclusive rights... [Read the full story]

People

IP Industry: we start here

March 8, 2015 · Leave a Comment 

In 2007, we set out to change the world of intellectual property, and how innovation and ideas were exchanged among IP owners and those that desired IP. We knew there were significant headwinds with an entrenched, decades-old ecosystem of long held beliefs about the “way things ought to be done” and who were we to come along and try to change things. None of this did anything to deter us; it drove us even harder. Not to gloat or brag, but many of the world’s LARGEST IP Owners and Transactors are now our customers- more on that in later posts.  They see the same future. IP Attorneys said... [Read the full story]

Deals

Revolutionary Concepts’ Signs Major Licensing Agreement for Royalties

  CHARLOTTE, N.C., April 17, 2015 (GLOBE NEWSWIRE) — Revolutionary Concepts Inc., (OTCPINK:REVO), a publicly traded company that owns patented mobile video software and remote security communication systems, announced that its global licensee Eyetalk365, LLC, has reached a settlement in its patent infringement lawsuit with an international... Read more of this article


San’an licenses Japanese LED patent portfolio to Luminus Devices

  San’an Optoelectronics Co., Ltd. today announced that it has licensed the United States patents of an LED patent portfolio it recently acquired from a major Japanese company to its subsidiary, Luminus Devices, Inc. The portfolio comprises over 125 issued patents, including over thirty United States patents as well as issued patents in China,... Read more of this article


DiaCarta Licenses U of Potsdam

  NEW YORK(GenomeWeb) – DiaCarta and the University of Potsdam today announced a licensing agreement for the non-invasive early detection of colon cancer. DiaCarta is licensing the intellectual property around the university’s detection method and will develop and commercialize a test to detect colon cancer directly from stool samples.... Read more of this article


Carclo enters CIT Technology licensing agreements

  Ossett-based hi-tech plastics company Carclo has agreed to license CIT Technology’s fine line technology (FLT) to UniPixel which will result in the “likely closure” of CIT’s Cambridge facility. In consideration for the grant of an initial five year FLT patent license to Unipixel, CIT will receive per annum payments of... Read more of this article


ChemRar, Lancet partner to develop and commercialize

  ChemRar High Tech Center (ChemRar), the Russian pharmaceutical investment and R&D group, and Lancet, Russian Distribution Company, have announced collaboration for research, development and commercialization of new medicines in Russia with the intention to stimulate the innovative development of the Russian pharmaceutical industry. Through... Read more of this article


VMware and Good Technology

  VMware and Good Technology have agreed to a long-term patent cross-licensing deal which puts an end to their ongoing legal battle. The full details of the patents involved in the litigation remain confidential, but in a joint statement, the pair said it related to both of their technology as well as that of VMware subsidiary Airwatch. Good and... Read more of this article


SELLAS Life Sciences Group and TrojanTec Sign Exclusive License Agreement

  NEW YORK and ZUG, Switzerland, April 15, 2015 /PRNewswire/ — SELLAS Life Sciences Group (SELLAS), a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive... Read more of this article


Nokia to take over Alcatel-Lucent

  Following much media speculation about Nokia’s and Alcatel-Lucent’s merger plans, Nokia today confirmed the companies’ intention to “combine” – with Nokia effectively taking over Alcatel-Lucent in an all-share transaction worth €15.6bn ($16.5bn). A Nokia statement said the deal will “create an innovation leader in... Read more of this article


PetVivo Holdings & Gel-Del Technologies Merger Completed

  MINNEAPOLIS, MN / ACCESSWIRE / April 14, 2015 / PetVivo Holdings, Inc. (PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices & therapeutics for pets is pleased to announce the completion of the merger between PetVivo and Gel-Del following satisfaction of the terms and conditions... Read more of this article


Commercialization Agreement for CAR-T Therapy Established by Intrexon and Merck Serono

  Intrexon Corporation , a pioneer in synthetic biology, and Merck Serono, the biotechnology and pharmaceutical company of Merck KGaA, Germany, established a collaborative licensing agreement for the development and commercialization of Chimeric Antigen Receptor T-cell (CAR-T) therapy. This partnership will allow the generation of a CAR-T platform... Read more of this article


More Posts From Deals

Legal

Semafone and Eckoh agree to settlement

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed... 


Iteris, Wavetronix Settle Patent Infringement Litigation

  SANTA ANA, Calif.–Iteris, Inc. (NYSE MKT: ITI), a leader in providing... 


More Posts From Legal

University Tech Transfer

DiaCarta Licenses U of Potsdam

  NEW YORK(GenomeWeb) – DiaCarta and the University of Potsdam today announced... 


Good Start Genetics Enters Exclusive License Agreement with Johns Hopkins University

  CAMBRIDGE, Mass.–(BUSINESS WIRE)–Good Start Genetics®, Inc.,... 


More Posts From University Tech Transfer